What type of drug is Olumiant (baricitinib)?
Olumiant is the brand name of the medicine called baricitinib which is a Janus kinase (JAK) inhibitor.
JAK inhibitors are intracellular enzymes that work by interfering with cytokine signaling to influence cell processes of immune cell function and inflammation.
Olumiant is used for rheumatoid arthritis treatment
Olumiant is an FDA approved medicine used alone or in combination with methotrexate or other non-biologic DMARDs for the treatment of moderate-to-severe rheumatoid arthritis (RA) in patients with an inadequate response to tumor necrosis factor (TNF) inhibitors.
In clinical trials, Olumiant had a significant response rate in RA compared to placebo after 12 weeks of treatment (49% versus 27% response rate, respectively). According to Eli Lilly, the price of Olumiant will be 60% less than the leading tumor necrosis factor (TNF) inhibitor.
Olumiant is used to treat severe alopecia areata.
Olumiant is a FDA approved medicine to treat adults with severe alopecia areata (severe hair loss).
Results from clinical trials for patients with 50% or greater scalp hair loss:
Olumiant 2mg a day for 36 weeks
- 17-22% patients achieved 80% or more scalp hair coverage.
- 11-13% patients achieved 90% or more scalp hair coverage.
Taking Olumiant 4 mg a day for 36 weeks
- 32-35% patients achieved 80% or more scalp hair coverage.
- 24-26% patients achieved 90% or more scalp hair coverage.
Olumiant can be used for COVID-19 Treatment
Olumiant has FDA approval to treat COVID-19 patients who are:
- 18 years and older, who are hospitalized and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO).
Olumiant has an Emergency Use Authorization (EUA) received from the FDA to treat COVID-19 patients who are:
- 2 years to less than 18 years of age, who are hospitalized and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or ECMO.
For a medicine to gain FDA approval, the evidence that shows it is effective has to be at a higher level and a larger quantity, compared to gaining EUA approval.
Baricitinib was studied for the treatment of COVID-19 In the Phase 3 COV-BARRIER study (NCT04421027). This was a randomized, double-blind, placebo-controlled study of hospitalized patients which compared baricitinib 4 mg once daily treatment plus standard of care, to placebo treatment with normal standard of care.
The results of the study showed that by day 28:
- Baricitinib patients were less likely to progress to needing ventilation or dying (Baricitinib group 27.8% and placebo group 30.5%)
- Baricitinib group had a reduced the risk of death (Baricitinib 8% and placebo group 13%)
Related questions
- What are the new drugs for rheumatoid arthritis (RA)?
- What are JAK inhibitors and how do they work?
- Which JAK inhibitors are approved in the U.S?
Bottom line:
- Olumiant (baricitinib) is a JAK inhibitor that influences immune cell function and inflammation.
- Olumiant is an FDA approved medicine used to treat severe alopecia areata and moderate to severe RA that has not responded well to another type of RA medicine called TNF inhibitors.
- Olumiant is FDA approved to treat COVID-19 patients who are 18 years and older, who are hospitalized and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO).
- Olumiant has an Emergency Use Authorization (EUA) to treat COVID-19 patients who are 2 years to less than 18 years of age, who are hospitalized and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or ECMO.
References
- Olumiant Professional Medication Information: [Accessed September 11, 2021] https://www.drugs.com/pro/olumiant.html
- Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial. [Accessed September 11, 2021] https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(21)00331-3/fulltext
- FDA Broadens Existing Emergency Use of Lilly and Incyte's Baricitinib in Patients Hospitalized with COVID-19 Requiring Oxygen. [Accessed September 11, 2021]. https://www.drugs.com/clinical_trials/fda-broadens-existing-emergency-lilly-incyte-s-baricitinib-patients-hospitalized-covid-19-requiring-19513.html
- Baricitinib Patient Information: [Accessed September 11, 2021] https://www.drugs.com/mtm/baricitinib.html
- FDA Approves Lilly and Incyte's Olumiant (baricitinib) as First and Only Systemic Medicine for Adults with Severe Alopecia Areata [Accessed June 22, 2022] https://www.drugs.com/newdrugs/fda-approves-lilly-incyte-s-olumiant-baricitinib-first-only-systemic-medicine-adults-severe-5851.html
Read next
How effective is Olumiant for alopecia (hair loss)?
In studies, about 17% to 35% of adults with severe alopecia areata achieved an 80% or greater scalp hair coverage at 36 weeks, as well as eyebrow and eyelash regrowth, depending upon their Olumiant dose. Some patients using the higher 4 mg dose saw 80% scalp hair regrowth at 24 weeks. Continue reading
Can you have Covid without a fever?
Yes, you can have Covid (coronavirus) without fever or with a very low-grade fever that is hardly noticeable, particularly with the Omicron variant. It is also possible to have Covid-19 with no symptoms at all and the only way you would know this is if you took a Covid-19 test. People infected with the coronavirus who have no symptoms can still spread COVID-19 to others. Continue reading
Can you become immune to COVID-19?
Patients who recover from COVID-19 make antibodies to the virus that may impart immunity for at least 6 months; however, breakthrough infections do occur and may be more likely with newly circulating variants of the virus. Immunizing with the latest recommended COVID-19 vaccine can help to extend your immunity and prevent disease. Continue reading
Related medical questions
- Is baricitinib (Olumiant) being used to treat COVID-19?
- Which breathing techniques help with COVID-19?
- Is Omicron worse than Delta?
- How effective is Lagevrio (molnupiravir) for COVID-19?
- Is obesity a major risk factor for Covid-19?
- Should I wear a face mask to protect myself from COVID-19?
- COVID-19 vaccines and variants: What you should know
- COVID-19: Why is social distancing so important?
- Why do more men die from coronavirus?
- Can Ivermectin be used to treat COVID-19?
- Can you take Ibuprofen if you have COVID-19 (coronavirus)?
- What antibiotics kill Covid-19 (coronavirus)?
- COVID-19: What are the Stages and Causes of Death?
- What's the difference between Bacteria and Viruses?
- Does Zinc protect you from Covid-19 or boost your immune system?
- How do I Treat Nasal Congestion with COVID-19?
- Does Losartan block the receptor used by the Coronavirus?
- An Update: Is hydroxychloroquine effective for COVID-19?
- Where can I buy an at-home test kit for COVID-19 (coronavirus)?
- Can you take Paxlovid twice if COVID rebounds?
- Does Mucinex help with Covid?
- Does Tamiflu (oseltamivir) work on COVID-19?
- Can vitamin C prevent or treat COVID-19 (coronavirus)?
- Should I take Paxlovid after a Positive COVID-19 Test?
- Can I take NyQuil with COVID or after the COVID vaccine?
- How long does COVID-19 last? and other COVID-19 FAQ
- How effective is Paxlovid for COVID-19?
- Do ACE inhibitors make COVID-19 worse?
- Can you take Ibuprofen after the COVID booster vaccine?
- Does methylprednisolone help with COVID?
Drug information
Related support groups
- Olumiant (6 questions, 4 members)
- Baricitinib (3 questions, 4 members)
- COVID-19 (106 questions, 88 members)
- Rheumatoid Arthritis (323 questions, 1,318 members)